Your Source for BioScience Venture Capital Data
  • SEARCH THE OnBioVC DATABASE:

  • OnBioVC NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • Photobucket

  • FDA Registered Contract Manufacturer

ZeaChem (Lakewood, CO) a development-stage biofuels company focused on cellulose-based biorefinery processes for producing ethanol, closed a $24M Series C financing. Participants include Birchmere Ventures, Firelake Capital, Globespan Capital Partners, Mohr Davidow Ventures, PrairieGold Venture Partners and Spring Ventures.

HealthTap (Palo Alto, CA) a web-based company focused on applications for the exchange of health information between patients and physicians, closed a $11.5M Series A financing. Participants include Mayfield Fund, Mohr Davidow Ventures and Innovation Endeavors.

OPX Biotechnologies (Boulder, CO) a development-stage biofuels company using synthetic biology to engineer the microbes as a bio-acrylic renewable fuel source, closed a $36.5M Series C financing. Participants include US Renewables Group, DBL Investors, Mohr Davidow Ventures, Braemar Energy Ventures, Altira Group and X/Seed Capital. Thanx for your patience as we catch-up.

Crescendo Bioscience (San Francisco, CA) a commercial-stage molecular diagnostics company focused on quantitative biomarker tests for rheumatoid, closed a $31M Series C financing. Participants include Aeris Capital, Mohr Davidow Ventures and Kleiner Perkins Caufield & Byers.

Genomatica (San Diego, CA) a development-stage biofuel company focused on chemical intermediates derived from renewable feedstock without additional processing steps, closed a $45M Series D financing. Participants include VantagePoint Venture Partners, TPG Biotech, Mohr Davidow Ventures, Alloy Ventures, Bright Capital, Waste Management and Draper Fisher Jurvetson.

Pacific Biosciences (Menlo Park, CA) developer of single molecule real-time nucleic acid and protein sequencing system closed a $50M Series F financing. Participants include Gen-Probe, Monsanto, the Wellcome Trust, Sutter Hill Ventures, Deerfield Management, Intel Capital, Morgan Stanley, Redmile Group, T. Rowe Price, Mohr Davidow Ventures, Kleiner Perkins Caufield and Byers, Alloy Ventures, Maverick Capital, [...]

iRhythm Technologies (San Francisco, CA) a commercial-stage medical device company focused on ambulatory cardiac monitors, closed a $10M Series C financing. Participants include St. Jude Medical, Mohr Davidow Ventures and Synergy Life Science Partners.

CardioDx (Palo Alto, CA) a commercial-stage cardiovascular molecular diagnostics company focused on coronary artery disease, cardiac arrhythmia and heart failure, closed a $5M Series D financing, bring the total round to $34.5M. Participants include GE Healthymagination Fund, Kleiner Perkins Caufield & Byers, TPG Biotech, Intel Capital, Mohr Davidow Ventures, DAG Ventures, Pappas Ventures and Asset [...]

Genomatica (San Diego, CA) a development-stage biofuel company focused on methods for adaptive evolution of microbes to achieve optimal performance under process conditions to produce industrial chemicals from carbohydrates, closed a $15M Series C financing. Participants include TPG Biotech, Mohr Davidow Ventures, Alloy Ventures and Draper Fisher Jurvetson.

Navigencis (Foster City, CA) a commercial-stage personalized genomics company, closed a $18M Series C financing. Participants include Procter & Gamble, Kleiner Perkins Caufield & Byers and Mohr Davidow Ventures.

On-Q-lty (Waltham, MA) a development stage molecular diagnostics company incorporating microfluidics and biomarker panels to predict response to cancer therapy based on DNA repair pathways in tumors, closed a $5M Series A financing, bringing the total round to $26M. Participants include Atlas Venture, Mohr Davidow Ventures, Bessemer Venture Partners, Physic Ventures and Northgate Capital. Note: [...]

Tethys Bioscience (Emeryville, CA) a commercial-stage diagnostics company focused on type II diabetes risk assessment through the measurement of multiple biomarkers, closed a $25M Series D financing. Participants include Capital AG, Wasatch Advisors, Mohr Davidow Ventures, Kleiner Perkins Caulfield & Byers and Intel Capital. Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

  

to top of page...